A brief historicity of the Diagnostic and Statistical Manual of Mental Disorders: Issues and implications for the future of psychiatric canon and practice

Philosophy, Ethics, and Humanities in Medicine

James Giordano²  Shadia Kawa¹ 

[1] Basic Biobehavioral and Psychological Sciences Branch, Behavioral Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, 6130 Executive Blvd., EPN 4066, Bethesda, MD 20892, USA;Oxford Centre for Neuroethics, Uehiro Centre for Practical Philosophy, University of Oxford, OX1, 1PT Oxford, UK

关键词: historicity;    mental disorders;    psychopathology;    nosology;    classification;    Psychiatry, DSM;   

Others  :  816498
DOI  :  10.1186/1747-5341-7-2

 received in 2011-12-12, accepted in 2012-01-13,  发布年份 2012

【 摘 要 】

The Diagnostic and Statistical Manual (DSM) of the American Psychiatric Association, currently in its fourth edition and considered the reference for the characterization and diagnosis of mental disorders, has undergone various developments since its inception in the mid-twentieth century. With the fifth edition of the DSM presently in field trials for release in 2013, there is renewed discussion and debate over the extent of its relative successes - and shortcomings - at iteratively incorporating scientific evidence on the often ambiguous nature and etiology of mental illness. Given the power that the DSM has exerted both within psychiatry and society at large, this essay seeks to analyze variations in content and context of various editions of the DSM, address contributory influences and repercussion of such variations on the evolving landscape of psychiatry as discipline and practice over the past sixty years. Specifically, we document major modifications in the definition, characterization, and classification of mental disorders throughout successive editions of the DSM, in light of shifting trends in the conceptualization of psychopathology within evolving schools of thought in psychiatry, and in the context of progress in behavioral and psychopharmacological therapeutics over time. We touch upon the social, political, and financial environments in which these changes took places, address the significance of these changes with respect to the legitimacy (and legitimization) of what constitutes mental illness and health, and examine the impact and implications of these changes on psychiatric practice, research, and teaching. We argue that problematic issues in psychiatry, arguably reflecting the large-scale adoption of the DSM, may be linked to difficulties in formulating a standardized nosology of psychopathology. In this light, we highlight 1) issues relating to attempts to align the DSM with the medical model, with regard to increasing specificity in the characterization of discrete mental disease entities and the incorporation of neurogenetic, neurochemical and neuroimaging data in its nosological framework; 2) controversies surrounding the medicalization of cognition, emotion, and behavior, and the interpretation of subjective variables as 'normal' or 'abnormal' in the context of society and culture; and 3) what constitutes treatment, enablement, or enhancement - and what metrics, guidelines, and policies may need to be established to clarify such criteria.

【 授权许可】

   
2012 Kawa and Giordano; licensee BioMed Central Ltd.

【 参考文献 】

• [1]American Psychiatric Association: Frequently Asked Questions, Diagnostic and Statistical Manual of Mental Disorders. [http://www.psych.org/MainMenu/Research/DSMIV/FAQs.aspx] webcite 2011.
• [2]Grob GN: Origins of DSM-I: of setting appearance and reality. Am J Psychiatry 1991, 148:421-31.
• [3]Klerman GL: Historical perspectives on contemporary schools of psychopathology. In Contemporary Directions and Psychopathology: Towards the DSM-IV. Edited by Millon T, Klerman GL. New York: The Guilford Press; 1986.
• [4]Double D: The limits of psychiatry. Brit Med Journal, Intl ed 2002, 324:900-4.
• [5]Raines GN: Comment: the new nomenclature. Am J Psychiatry 1953, 109:548-549.
• [6]American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. 1st edition. Washington, DC: American Psychiatric Association; 1952.
• [7]Pressman JD: Psychiatry and its origins. Bull Hist Med 1997, 71:129-139.
• [8]Grob GN: Psychiatry's holy grail: the search for the mechanisms of mental diseases. Bull Hist Med 1998, 72:189-219.
• [9]Braslow JT: Therapeutics in the history of psychiatry. Bull Hist Med 2000, 74:794-802.
• [10]American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. 2nd edition. Washington, DC: American Psychiatric Association; 1968.
• [11]Spitzer RL, Wilson PT: Section 7: A guide to the new nomenclature. In American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders. 2nd edition. Washington, DC: American Psychiatric Association; 1968:122-123.
• [12]Wilson M: DSM-III and the transformation of American psychiatry: a history. Am J Psychology 1993, 150:399-410.
• [13]Millon T, Klerman GL (Eds): Contemporary Directions and Psychopathology: Towards the DSM-IV. New York: The Guilford Press; 1986.
• [14]Mayes R, Horwitz A: DSM-III and the revolution in the classification of mental illness. J Hist Behav Sci 2005, 41:249-267.
• [15]Ban TA: Pharmacotherapy of mental illness -a historical analysis. Prog Neuropsychopharmacol Biol Psychiatry 2001, 25:709-727.
• [16]Redlich F, Kellert S: Trends in American mental health. Am J Psychiatry 1978, 135:22-28.
• [17]Spitzer RL, Endicott J, Robins E: Research Diagnostic Criteria: Rationale and Reliability. Arch Gen Psychiatry 1978, 35:773-782.
• [18]American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. 3rd edition. Washington, DC American Psychiatric Association; 1980.
• [19]Bayer R, Spitzer RL: Neurosis, psychodynamics, and DSM-III. A history of the controversy. Arch Gen Psychiatry 1985, 42:187-196.
• [20]American Psychiatric Association: Appendix C-Annotated comparative Listing of DSM-II and DSM-III. In American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. 3rd edition. Washington, DC: American Psychiatric Association; 1980.
• [21]American Psychiatric Association: Use of This Manual. In American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. 3rd edition. Washington, DC: American Psychiatric Association; 1980.
• [22]American Psychiatric Association: DSM-III, "Introduction". In American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. 3rd edition. Washington, DC: American Psychiatric Association; 1980.
• [23]Sabshin M: Turning points in twentieth-century American psychiatry. Am J Psychiatry 1990, 147:1267-1274.
• [24]Klerman GL, Vaillant GE, Spitzer RL, Michels R: A Debate on DSM-III. Am J Psychiatry 1984, 141:539-53.
• [25]Young A: The Harmony of Illusions: inventing Post-Traumatic Stress Disorder. Princeton, NJ: Princeton University Press; 1995.
• [26]Klerman LG: The National Institute of Mental Health - Epidemiologic Catchment Area (NIMH-ECA) program. Soc Psychiatry 1986, 21:159-166.
• [27]Gambardella A: Science and Innovation: The US Pharmaceutical Industry During the I980s. Cambridge, MA: Cambridge University Press; 1995.
• [28]Hall L: The biology of mental disorders. Journal of the American Medical Association 1993, 269:844.
• [29]American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. 3rd edition. Washington, DC: American Psychiatric Association; 1987.
• [30]American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. 4th edition. Washington, DC: American Psychiatric Association; 1994.
• [31]American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. 4th edition. Washington, DC: American Psychiatric Association; 2000.
• [32]Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS: Lifetime and I2-month prevalence of DSM-III-R psychiatric disorders in the United States results from the National Comorbidity Survey. Arch Gen Psychiatry 1994, 51:8-19.
• [33]Rogler LH: Making sense of historical changes in the Diagnostic and Statistical Manual of Mental Disorders: Five propositions. J Health Soc Behav 1997, 38:9-20.
• [34]Giordano J (Ed): Advances in Neurotechnology: Premises, Potential and Problems. Boca Raton, Florida: CRC Press; 2012.
• [35]Patil T, Giordano J: Ontological assumptions of the medical model of psychiatry. Philos Ethics Humanit Med 2010, 5:3. BioMed Central Full Text
• [36]Lane C: How shyness became all illness: a brief history of social phobia. In Symposium: Unsocial Thought, Uncommon Lives, Common Knowledge. Volume 12. Durham: Duke University Press; 2006::388-409.
• [37]Cassels A: Selling sickness: how the world's biggest pharmaceutical companies are turning us all into patients. New York: Nation Books; 2005.
• [38]Breggin PR: Toxic psychiatry: why therapy, empathy, and love must replace the drugs, electroshock and biochemical theories of the "New Psychiatry". New York: St. Martins; 1991.
• [39]Healy D: Let them eat Prozac: the unhealthy relationship between the plumnaceutical industry and depression. New York: New York University Press; 2004.
• [40]Gini A, Giordano J: The human condition and strivings to flourish. In Scientific and Philosophical Perspectives in Neuroethics. Edited by Giordano J, Gordijn B. Cambridge: Cambridge University Press; 2010.
• [41]Singh I, Kelleher KJ: Neuroenhancement in Young People: Proposal for Research, Policy, and Clinical Management. American J of Bioethics- Neuroscience 2010, 1:3-16.
• [42]Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE: Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005, 62:593-602.
• [43]Gini A, Rossi J, Giordano J: Considering enhancement and treatment: On the need to regard contingency and develop dialectic evaluation. AJOB-Neuroscience 2010, 1:25-27.
• [44]Rosenberg CE: The tyranny of diagnosis: specific disease entities and individual experience. Milbank Q 2002, 80:237-60.
• [45]Waller JC: Ideas of heredity, reproduction and eugenics in Britain, 1800-1875. Studies in History and Philosophy of Science 2001, 32:457-489.
• [46]Galton D: Eugenics: some lessons from the past. Reprod Biomed Online 2005, 10(Suppl 1):133-136.
• [47]Watson G: Psychology under Hitler. School & Society 1933, 38:732-736.
• [48]Thom A, Caregorodcev G: Medizin unterm Hakenkreuz. Berlin: Verlag Volk und Gesundheit; 2010.
• [49]Potomac Institute for Policy Studies: Video: Second Cyber Challenge Symposium: Nanoscience, Neuroscience and Genetics. [http:/ / www.potomacinstitute.org/ index.php?option=com_content&view=a rticle&id = 867:second-cyber-challe nge-symposium-set-for-february-17th &catid = 65:past-events&Itemid = 94] webcite 2011.
• [50]Jutel A: Sociology of diagnosis: a preliminary review. Sociol Health Illn 2009, 31:278-299.
• [51]Sadler JZ, Hulgus YF, Agich GJ: On values in recent American psychiatric classification. J Med Phil 1994, 19:261-277.
• [52]Spitzer RL: Values and assumptions in the development of DSM-III and DSM-III-R: An insider's perspective and a belated response to Sadler, Hulgus, and Agich 's "On values in recent American psychiatric classification". J Nerv Ment Dis 2001, 189:351-359.